Pfizer Issues Financials for Second Quarter of 2019
July 29, 2019
July 29, 2019
NEW YORK, July 29 -- Pfizer, a pharmaceutical company, issued the following news release:
Due to today's announcement of a proposed transaction between Pfizer and Mylan, Pfizer's second-quarter 2019 earnings conference call with investment analysts has been rescheduled for today, July 29, 2019, at 10:30 a.m. EDT. This call was previously scheduled for Tuesday, July 30, 2019 at 10 a.m. EDT.
To view and listen to the webcast and view the Performance Report, visit our web . . .
Due to today's announcement of a proposed transaction between Pfizer and Mylan, Pfizer's second-quarter 2019 earnings conference call with investment analysts has been rescheduled for today, July 29, 2019, at 10:30 a.m. EDT. This call was previously scheduled for Tuesday, July 30, 2019 at 10 a.m. EDT.
To view and listen to the webcast and view the Performance Report, visit our web . . .